Skip to main content
Top
Published in: Internal and Emergency Medicine 2/2020

01-03-2020 | Antibiotic | IM - ORIGINAL

Procalcitonin in hemodialysis patients presenting with fever or chills to the emergency department

Authors: R. Schneider, M. J. Cohen, S. Benenson, O. Duchin, Y. S. Haviv, M. Elhalel-Darnitski, P. D. Levin

Published in: Internal and Emergency Medicine | Issue 2/2020

Login to get access

Abstract

We sought to assess the role of procalcitonin in discriminating severe bacterial infections requiring antibiotic treatment from non-bacterial causes of fever or chills in chronic dialysis patients. Chronic hemodialysis patients who were admitted to the emergency room due to fever and/or chills were recruited to the study. The presence or absence of bacterial infection was defined after recruitment conclusion by an infectious disease specialist who was blinded to procalcitonin results. Procalcitonin levels were compared between infected and non-infected patients. Out of 54 patients recruited, 22 (41%) patients eventually diagnosed with infection. Mean (± SD) procalcitonin values were 4.3 (± 5.5) ng/ml among cases, 1.0 (± 2.0) ng/ml among controls with no infection (p = 0.02). A cutoff PCT value of 1 ng/ml or higher had 77% sensitivity and 59% specificity for the diagnosis of severe infection. Procalcitonin cannot usefully identify hemodialysis patient with bacterial infection.
Literature
1.
go back to reference Arulkumaran N, Montero RM, Singer M (2012) Management of the dialysis patient in general intensive care. Br J Anaesth 108:183–192CrossRef Arulkumaran N, Montero RM, Singer M (2012) Management of the dialysis patient in general intensive care. Br J Anaesth 108:183–192CrossRef
2.
go back to reference Powe NR, Jaar B, Furth SL, Hermann J, Briggs W (1999) Septicemia in dialysis patients: incidence, risk factors, and prognosis. Kidney Int 55:1081–1090CrossRef Powe NR, Jaar B, Furth SL, Hermann J, Briggs W (1999) Septicemia in dialysis patients: incidence, risk factors, and prognosis. Kidney Int 55:1081–1090CrossRef
3.
go back to reference Herget-Rosenthal S, Marggraf G, Pietruck F et al (2001) Procalcitonin for accurate detection of infection in haemodialysis. Nephrol Dial Transplant 16:975–979CrossRef Herget-Rosenthal S, Marggraf G, Pietruck F et al (2001) Procalcitonin for accurate detection of infection in haemodialysis. Nephrol Dial Transplant 16:975–979CrossRef
4.
go back to reference Meisner M, Brunkhorst FM, Reith HB, Schmidt J, Lestin HG, Reinhart K (2000) Clinical experiences with a new semi-quantitative solid phase immunoassay for rapid measurement of procalcitonin. Clin Chem Lab Med 38:989–995CrossRef Meisner M, Brunkhorst FM, Reith HB, Schmidt J, Lestin HG, Reinhart K (2000) Clinical experiences with a new semi-quantitative solid phase immunoassay for rapid measurement of procalcitonin. Clin Chem Lab Med 38:989–995CrossRef
5.
go back to reference Horan TC, Andrus M (2008) CDC/NHSN Surveillance Definitions for Specific Types of Infections. Am J Infect Control. 36:309–322CrossRef Horan TC, Andrus M (2008) CDC/NHSN Surveillance Definitions for Specific Types of Infections. Am J Infect Control. 36:309–322CrossRef
6.
go back to reference Abramson JH (2011) WINPEPI updated: computer programs for epidemiologists, and their teaching potential. Epidemiol Perspect Innov 8:1CrossRef Abramson JH (2011) WINPEPI updated: computer programs for epidemiologists, and their teaching potential. Epidemiol Perspect Innov 8:1CrossRef
7.
go back to reference Abramson JH (2004) WINPEPI (PEPI-for-Windows): computer programs for epidemiologists. Epidemiol Perspect Innov 1:6CrossRef Abramson JH (2004) WINPEPI (PEPI-for-Windows): computer programs for epidemiologists. Epidemiol Perspect Innov 1:6CrossRef
8.
go back to reference Bland M (2000) An introduction to medical statistics, 3rd edn. Oxford University Press, Oxford Bland M (2000) An introduction to medical statistics, 3rd edn. Oxford University Press, Oxford
9.
go back to reference Dumea R, Siriopol D, Hogas S, Mititiuc I, Covic A (2014) Procalcitonin: diagnostic value in systemic infections in chronic kidney disease or renal transplant patients. Int Urol Nephrol 46:461–468CrossRef Dumea R, Siriopol D, Hogas S, Mititiuc I, Covic A (2014) Procalcitonin: diagnostic value in systemic infections in chronic kidney disease or renal transplant patients. Int Urol Nephrol 46:461–468CrossRef
10.
go back to reference El-Sayed D, Grotts J, Golgert WA, Sugar AM (2014) Sensitivity and specificity of procalcitonin in predicting bacterial infections in patients with renal impairment. Open Forum Infect Dis 1:68CrossRef El-Sayed D, Grotts J, Golgert WA, Sugar AM (2014) Sensitivity and specificity of procalcitonin in predicting bacterial infections in patients with renal impairment. Open Forum Infect Dis 1:68CrossRef
11.
go back to reference Montagnana M, Lippi G, Tessitore N et al (2009) Procalcitonin values after dialysis is closely related to type of dialysis membrane. Scand J Clin Lab Invest 69:703–707CrossRef Montagnana M, Lippi G, Tessitore N et al (2009) Procalcitonin values after dialysis is closely related to type of dialysis membrane. Scand J Clin Lab Invest 69:703–707CrossRef
12.
go back to reference Quiroga B, Villaverde M, Vega A, Abad S, Reque J, Lopez-Gomez JM (2014) Procalcitonin as an early predictor of acute infection in hemodialysis patients. Nefrologia 34:341–346PubMed Quiroga B, Villaverde M, Vega A, Abad S, Reque J, Lopez-Gomez JM (2014) Procalcitonin as an early predictor of acute infection in hemodialysis patients. Nefrologia 34:341–346PubMed
13.
go back to reference Mann EA, Wood GL, Wade CE (2011) Use of procalcitonin for the detection of sepsis in the critically ill burn patient: a systematic review of the literature. Burns 37:549–558CrossRef Mann EA, Wood GL, Wade CE (2011) Use of procalcitonin for the detection of sepsis in the critically ill burn patient: a systematic review of the literature. Burns 37:549–558CrossRef
14.
go back to reference Ren H, Li Y, Han C, Hu H (2013) Serum procalcitonin as a diagnostic biomarker for sepsis in burned patients: a meta-analysis. Burns 41:502–509CrossRef Ren H, Li Y, Han C, Hu H (2013) Serum procalcitonin as a diagnostic biomarker for sepsis in burned patients: a meta-analysis. Burns 41:502–509CrossRef
15.
go back to reference Parli SE, Trivedi G, Woodworth A, Chang PK (2018) Procalcitonin: Usefulness in Acute Care Surgery and Trauma. Surg Infect (Larchmt) 19:131–136CrossRef Parli SE, Trivedi G, Woodworth A, Chang PK (2018) Procalcitonin: Usefulness in Acute Care Surgery and Trauma. Surg Infect (Larchmt) 19:131–136CrossRef
16.
go back to reference Li S, Rong H, Guo Q, Chen Y, Zhang G, Yang J (2016) Serum procalcitonin levels distinguish Gram-negative bacterial sepsis from Gram-positive bacterial and fungal sepsis. J Res Med Sci 21:39CrossRef Li S, Rong H, Guo Q, Chen Y, Zhang G, Yang J (2016) Serum procalcitonin levels distinguish Gram-negative bacterial sepsis from Gram-positive bacterial and fungal sepsis. J Res Med Sci 21:39CrossRef
17.
go back to reference Guo SY, Zhou Y, Hu QF, Yao J, Wang H (2015) Procalcitonin is a marker of gram-negative bacteremia in patients with sepsis. Am J Med Sci 349:499–504CrossRef Guo SY, Zhou Y, Hu QF, Yao J, Wang H (2015) Procalcitonin is a marker of gram-negative bacteremia in patients with sepsis. Am J Med Sci 349:499–504CrossRef
18.
go back to reference Pieralli F, Corbo L, Torrigiani A et al (2017) Usefulness of procalcitonin in differentiating Candida and bacterial blood stream infections in critically ill septic patients outside the intensive care unit. Intern Emerg Med 12:629–635CrossRef Pieralli F, Corbo L, Torrigiani A et al (2017) Usefulness of procalcitonin in differentiating Candida and bacterial blood stream infections in critically ill septic patients outside the intensive care unit. Intern Emerg Med 12:629–635CrossRef
19.
go back to reference Cortegiani A, Misseri G, Ippolito M et al (2019) Procalcitonin levels in candidemia versus bacteremia: a systematic review. Crit Care 23:190CrossRef Cortegiani A, Misseri G, Ippolito M et al (2019) Procalcitonin levels in candidemia versus bacteremia: a systematic review. Crit Care 23:190CrossRef
20.
go back to reference Jereb M, Kotar T, Jurca T, Lejko Zupanc T (2009) Usefulness of procalcitonin for diagnosis of infective endocarditis. Intern Emerg Med 4:221–226CrossRef Jereb M, Kotar T, Jurca T, Lejko Zupanc T (2009) Usefulness of procalcitonin for diagnosis of infective endocarditis. Intern Emerg Med 4:221–226CrossRef
21.
go back to reference Yu CW, Juan LI, Hsu SC et al (2013) Role of procalcitonin in the diagnosis of infective endocarditis: a meta-analysis. Am J Emerg Med 31:935–941CrossRef Yu CW, Juan LI, Hsu SC et al (2013) Role of procalcitonin in the diagnosis of infective endocarditis: a meta-analysis. Am J Emerg Med 31:935–941CrossRef
22.
go back to reference Grace E, Turner RM (2014) Use of procalcitonin in patients with various degrees of chronic kidney disease including renal replacement therapy. Clin Infect Dis 59:1761–1767CrossRef Grace E, Turner RM (2014) Use of procalcitonin in patients with various degrees of chronic kidney disease including renal replacement therapy. Clin Infect Dis 59:1761–1767CrossRef
23.
go back to reference Bouadma L, Luyt CE, Tubach F et al (2010) Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 375:463–474CrossRef Bouadma L, Luyt CE, Tubach F et al (2010) Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 375:463–474CrossRef
24.
go back to reference de Jong E, van Oers JA, Beishuizen A et al (2016) Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis 16:819–827CrossRef de Jong E, van Oers JA, Beishuizen A et al (2016) Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis 16:819–827CrossRef
Metadata
Title
Procalcitonin in hemodialysis patients presenting with fever or chills to the emergency department
Authors
R. Schneider
M. J. Cohen
S. Benenson
O. Duchin
Y. S. Haviv
M. Elhalel-Darnitski
P. D. Levin
Publication date
01-03-2020
Publisher
Springer International Publishing
Keyword
Antibiotic
Published in
Internal and Emergency Medicine / Issue 2/2020
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-019-02156-7

Other articles of this Issue 2/2020

Internal and Emergency Medicine 2/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine